首页> 美国卫生研究院文献>Lung India : Official Organ of Indian Chest Society >Concomitant expression of exon 19 mutation epidermal growth factor receptor and anaplastic lymphoma kinase gene rearrangement in metastatic adenocarcinoma lung responsive to crizotinib

【2h】

Concomitant expression of exon 19 mutation epidermal growth factor receptor and anaplastic lymphoma kinase gene rearrangement in metastatic adenocarcinoma lung responsive to crizotinib

机译：外显子19突变表皮生长因子受体的表达与间变性淋巴瘤激酶基因重排在对克唑替尼有反应的转移性肺腺癌中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Lung India : Official Organ of Indian Chest Society
作者
Abhishek Purkayastha; Amul Kapoor; Harinder Pal Singh; Arti Sarin; Prasanta Sengupta; Sankalp Singh; Niharika Bisht; Azhar Husain;
展开▼
作者单位

展开▼
年(卷),期 2018(35),6
年度 2018
页码 527–529
总页数 7
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [J] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, BMC research notes . 2013 ,第1期

机译：对克唑替尼具有耐药性的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变
2. A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor epidermal growth factor receptor mutations and anaplastic lymphoma kinase anaplastic lymphoma kinase rearrangement [J] . Harada Daijiro, Kozuki Toshiyuki, Nogami Naoyuki, Asia-Pacific journal of clinical oncology . 2019 ,第4期

机译：每周Nab-紫杉醇的一期I / II试验用于预处理的非小细胞肺癌患者，没有表皮生长因子受体表皮生长因子受体突变和包血性淋巴瘤激素抑制淋巴瘤激酶重排
3. Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement [J] . Zhou Jianya, Zheng Jing, Zhao Jing, Thoracic cancer. . 2015 ,第2期

机译：伴随表皮生长因子受体突变和间变性淋巴瘤激酶重排的肺腺癌对吉非替尼的不良反应
4. Metabolomics approach for mice serum associated with epidermal growth factor receptor and BaP-induced mouse lung tumorigenesis using liquid chromatography-mass spectrometry [C] . Pinpin Lin, Chao-Yu Chen, Jhih-Sheng Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：使用液相色谱 - 质谱法与表皮生长因子受体相关的小鼠血清的代谢组种方法，液相色谱 - 质谱法
5. The characteristics of the course of the disease in lung adenocarcinoma in relation to activating mutations of the gene for epidermal growth factor receptor. [D] . Stanic, Karmen. 2015

机译：与表皮生长因子受体基因激活突变有关的肺腺癌疾病病程特征。
6. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [O] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, 2013

机译：对克唑替尼耐药的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变
7. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report [O] . Henrik H Rossing, Morten Grauslund, Edyta M Urbanska, 2013

机译：对克唑替尼具有耐药性的ALK（间变性淋巴瘤激酶）阳性肺腺癌患者同时发生EGFR（表皮生长因子受体）和KRAS（V-Ki-ras2 Kirsten大鼠肉瘤病毒癌基因同源物）突变

Concomitant expression of exon 19 mutation epidermal growth factor receptor and anaplastic lymphoma kinase gene rearrangement in metastatic adenocarcinoma lung responsive to crizotinib

著录项

相似文献

相关主题

期刊订阅